Importantly, bone marrow samples from patients with AML had significantly reduced FBXO11 protein abundance relative to normal cord blood CD34+ HSPC (Figure 2, C and D), or adult bone marrow CD34+ HSPC (Supplemental Figure 2, E and F). This evidence concerns the gene CD34 and acute myeloid leukemia.